FDA Authorizes First At-Home Chlamydia, Gonorrhea Test

Simple 2 Test available OTC as first FDA-authorized test with at-home sample collection for any sexually transmitted disease other than HIV. 

• Source: Shutterstock

The US Food and Drug Administration grants marketing authorization for LetsGetChecked's Simple 2 Test, the first FDA-authorized diagnostic test for chlamydia and gonorrhea with at-home sample collection.

Prior to the agency’s authorization on 15 November for LetsGetChecked, the business name for PrivaPath Diagnostics Ltd., the only...

More from Regulation

EU Industry Wants EFSA Changes To Support Innovation

 
• By 

Prominent trade groups call on the European Commission to improve risk assessment of innovative food products by making changes to processes at the European Food Safety Authority.

US FDA Clarifies Success For An NDI Notification Fits Only The Notifier’s Ingredient

Along with two instructional videos, FDA provides fact sheet detailing common problems with NDINs while supplement industry awaits guidance on two hurdles for clearing the NDIN process, providing identity information and evidence of safety for ingredients.

AESGP Annual Meeting: Harmonizing EU VMS Max Levels Could Cost Sector Over €200m

 
• By 

Limited capacity and a two-to-three year timescale for reformulation could mean that many VMS supplements disappear from the market, warns EPPA partner Alexandra Bocquillion, speaking at the AESGP Annual Meeting in Warsaw, Poland.

FDA’s FY 2026 Budget Request Lacks New Policy Proposals

 
• By 

The White House requested $6.8bn for the FDA, down 3.9% from the current funding level, but does not propose any legislative changes. In previous years, the agency used the budget process to seek statutory fixes specific to generic drugs and shortages.

More from Policy & Regulation